Real-world evaluation of physiotherapist-led exercise prehabilitation and rehabilitation during autologous stem cell transplantation in myeloma: a single-centre experience

被引:0
|
作者
Land, Joanne [1 ,2 ]
Luong, Michael K. [1 ]
Longden, Alasdair [1 ]
Rabin, Neil [1 ]
Kyriakou, Charalampia [1 ]
Sive, Jonathan [1 ]
Fisher, Abi [3 ]
Yong, Kwee [2 ]
Mccourt, Orla [1 ,2 ]
机构
[1] Univ Coll London Hosp NHS Fdn Trust, Dept Haematol, London, England
[2] UCL, UCL Canc Inst, London, England
[3] UCL, Res Dept Behav Sci & Hlth, London, England
关键词
Exercise; Allied Health Occupations; Rehabilitation; Telemedicine; 6-MINUTE WALK TEST; MULTIPLE-MYELOMA; STRENGTH;
D O I
10.1136/bmjoq-2024-002936
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background There is emerging evidence for the role of exercise in optimising function, quality of life (QoL) and reducing hospital length-of-stay if commenced prior to undergoing autologous stem cell transplantation (ASCT). A local pilot study of a prehabilitation and rehabilitation intervention during ASCT for myeloma patients indicated promising results and was adapted to translate into local clinical care. The aim of this report is to describe an overview of a newly implemented physiotherapist-led exercise prehabilitation and rehabilitation service delivered as part of the myeloma ASCT pathway, and present real-world findings related to changes in function and QoL.Methods A service evaluation was conducted at a single-centre tertiary referral hospital for haematopoetic stem cell transplantation in the United Kingdom. A hybrid service using face-to-face clinical assessments and weekly remotely supervised group exercise, via an online video conferencing platform, in the phase between stem cell harvest and admission (prehabilitation), and from discharge to 100 days post-ASCT (rehabilitation). Functional (6 min walk and timed sit-to-stand tests) and patient-reported outcome measures (European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-C30) and EuroQol EQ5D-5L were assessed at preharvest, preadmission and in the post-ASCT evaluation (day 100) clinic.Results Patients (n=46) with a diagnosis of multiple myeloma referred for ASCT following induction chemotherapy were assessed. Baseline assessments showed high prevalence of impaired function and lower limb strength. Improvements were evident following prehabilitation prior to admission, which were maintained post-ASCT. Changes in 6 min walk test and timed sit-to-stand were significant and beyond thresholds of clinical importance. Improvements were also seen in the domains of QoL.Conclusions Implementation of physiotherapist-led assessments in the myeloma clinic and group exercise delivery under remote supervision are acceptable to patients undergoing ASCT and indicate benefit in improving function and QoL.
引用
收藏
页数:10
相关论文
共 27 条
  • [21] Impact of the changing landscape of induction therapy prior to autologous stem cell transplantation in 540 newly diagnosed myeloma patients: a retrospective real-world study
    Wang, Song-Yau
    Holzhey, Tanja
    Heyn, Simone
    Zehrfeld, Thomas
    Fricke, Susann
    Hoffmann, Franz Albert
    Becker, Cornelia
    Braunert, Leanthe
    Edelmann, Thomas
    Paulenz, Inessa
    Hitzschke, Marcus
    Flade, Franziska
    Schwarzer, Andreas
    Fenchel, Klaus
    Franke, Georg-Nikolaus
    Vucinic, Vladan
    Jentzsch, Madlen
    Schwind, Sebastian
    Hell, Saskia
    Backhaus, Donata
    Lange, Thoralf
    Niederwieser, Dietger
    Scholz, Markus
    Platzbecker, Uwe
    Poenisch, Wolfram
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 3739 - 3752
  • [22] Upfront tandem autologous non-myeloablative allogeneic stem cell transplant in high-risk multiple myeloma: a long-term single-centre experience
    Nguyen, Phillip C.
    Muirhead, Jenny
    Tan, Joanne
    Kalff, Anna
    Bergin, Krystal
    Walker, Patricia
    Spencer, Andrew
    INTERNAL MEDICINE JOURNAL, 2022, 52 (07) : 1263 - 1267
  • [23] Real-World Analysis of Characteristics and Main Outcomes of Multiple Myeloma Patients: Impact of Prognostic Scores, Access to Novel Agents and Autologous Stem-Cell Transplantation
    Ferreira, Flavia
    Lacerda, Marcelo
    Figueiredo, Pedro
    Zing, Natalia
    Araujo, Camila
    Reis, Isabel
    Nascimento, Anderson
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 : S239 - S240
  • [24] Real-world advantage and challenge of post-autologous stem cell transplantation MRD negativity in high-risk patients with double-hit multiple myeloma
    Tao, Yi
    Jin, Shiwei
    Yang, Dan
    Pan, Mengmeng
    Ouyang, Wanyan
    Liu, Yuanfang
    Wang, Yan
    Zhang, Weiping
    Mi, Jianqing
    BMC CANCER, 2024, 24 (01)
  • [25] Real-world advantage and challenge of post-autologous stem cell transplantation MRD negativity in high-risk patients with double-hit multiple myeloma
    Yi Tao
    Shiwei Jin
    Dan Yang
    Mengmeng Pan
    Wanyan Ouyang
    Yuanfang Liu
    Yan Wang
    Weiping Zhang
    Jianqing Mi
    BMC Cancer, 24
  • [26] Tandem Autologous Stem Cell Transplantation Does Not Benefit fi t High-Risk Myeloma Patients in the Maintenance Era: Real-World Results from The Canadian Myeloma Research Group Database
    Venner, Christopher P.
    Duggan, Peter
    Song, Kevin
    Reece, Donna
    Sharma, Smriti
    Su, Jiandong
    Jimenez-Zepeda, Victor H.
    McCurdy, Arleigh
    Louzada, Martha
    Mian, Hira
    Sebag, Michael
    White, Darrell
    Stakiw, Julie
    Kotb, Rami
    Aslam, Muhammad
    Reiman, Anthony
    Gul, Engin
    Chu, Michael P.
    Bergstrom, Debra
    LeBlanc, Richard
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (09): : 889 - 901
  • [27] Efficacy of diverse high-dose regimens followed by autologous peripheral blood stem cell transplantation in consecutive multiple myeloma patients: a single-centre analysis over a 12-year period
    P. S. Haas
    K. Bauchmüller
    A. Kühnemund
    J. Finke
    G. Ihorst
    M. Engelhardt
    Annals of Hematology, 2006, 85 : 191 - 193